Results 111 to 120 of about 5,044,916 (330)
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez +13 more
wiley +1 more source
IA1 microinvasive cervical adenocarcinoma in a young woman
Introduction: The expansion of cytological screening programs for cervical cancer leads to an increase in the proportion of both adenocarcinomas and diagnoses in young women with reproductive intention.
Barbara Tavares +4 more
doaj
Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysis [PDF]
Takeshi Terashima +11 more
openalex +1 more source
Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
ABSTRACT Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.
Molly Mack +12 more
wiley +1 more source
Progressing towards acceptable treatment outcomes
Pain 144 (2009) 228-229.
Centre for Pain Research, School for Health, University of Bath +3 more
openaire +3 more sources
ABSTRACT Background We describe clinical and biologic characteristics of neuroblastoma in older children, adolescents, and young adults (OCAYA); describe survival outcomes in the post‐immunotherapy era; and identify if there is an age cut‐off that best discriminates outcomes.
Rebecca J. Deyell +14 more
wiley +1 more source
Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan [PDF]
Hikmat Abdel‐Razeq +6 more
openalex +1 more source
ABSTRACT Background Despite their increased risk for functional impairment resulting from cancer and its treatments, few adolescents and young adults (AYAs) with a hematological malignancy receive the recommended or therapeutic dose of exercise per week during inpatient hospitalizations.
Jennifer A. Kelleher +8 more
wiley +1 more source
Evaluating innovation policy: a structural treatment effect model of R&D subsidies [PDF]
This paper studies the welfare effects of R&D subsidies. We develop a model of continuous optimal treatment with outcome heterogeneity where the treatment outcome depends on applicant investment.
Takalo, Tuomas +2 more
core

